Gene patenting report implicates all R&D
16 February, 2011Senate’s gene patenting report fails to offer solutions to Australian healthcare industry.
New independent ethical science and research committee
02 February, 2011Australian taxpayers can be confident the research activities they fund meet the highest ethical and moral standards thanks to the establishment of the government’s Australian Research Integrity Committee.
Independent MPs support boost for R&D
30 November, 2010Businesses will get more support for research and development under legislation passed by the House of Representatives.
New standard for describing marker genes
30 November, 2010An international community of scientists, the Genomic Standards Consortium, has published a new standard for describing marker genes.
Government introduces R&D tax credit
15 October, 2010The Gillard government has introduced the R&D Tax Credit to replace the existing R&D Tax Concession with a claimed to be more certain and more generous R&D incentive to business, particularly SMEs.
Protecting genetic resources
04 May, 2010Comparing the conformity of molecular markers is considered a first step in determining what the 'essential characteristics' of a particular plant variety are.
Win for personalised medicine in US DNA patent case
06 April, 2010In a ruling that will most definitely advance the development of personalised, molecular medicine and the practice of molecular pathology, a US district court has found against gene patenting.
New in vitro diagnostic regulations legislated
04 March, 2010The regulation of in vitro diagnostics in Australia will undergo significant change as pre-market regulatory approval and inclusion on the Australian Register of Therapeutic Goods is required for IVD devices under the new regulatory scheme, which comes into force on 1 July 2010.
Harmonised classification and labelling for three chemical substances
29 January, 2010Indium phosphide, di-tert-butyl peroxide and trixylyl phosphate have been looked at by the Committee for Risk Assessment (RAC) of ECHA (European Chemicals Agency in Helsinki).
15 new substances of very high concern to be added to the Candidate List
08 December, 2009The ECHA Member State Committee has identified 15 new chemical substances for the Candidate List of substances of very high concern which will be added to the Candidate List in January 2010.
Global patent application backlog passes 4.2 million
24 September, 2009The current backlog of patent applications has passed 4.2 million and is growing unsustainably.
UWA considers intellectual property judgement
04 September, 2009The University of Western Australia is considering its options following a judgement from the Full Bench of the Federal Court relating to the University’s right to protect its investment in intellectual property developed by its staff.
Implications of genetic testing
02 September, 2009 by Janette WoodhouseAustralia does not have any legislation in place to regulate how, and by whom, genetic test results can be used.
Code of Practice for the design and fabrication of thermoplastic vessels
27 August, 2009Dotmar has been working with the plastic fabrication industry within Australia and New Zealand, Australian Standards and key suppliers to develop an Australian Code of Practice for the fabrication of thermoplastic vessels.
Faster, better patent processing in Europe
04 May, 2009Current patent data processing technologies are not up to present and future challenges with large bottlenecks holding up thousands of patent applications all over the world. In Europe, the PATExpert project is offering some solutions.
